世界の線維筋痛症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Fibromyalgia Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2361 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、線維筋痛症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（セロトニン・ノルアドレナリン再取り込み阻害薬、GABAアナログ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・線維筋痛症治療薬の市場動向 ・企業の競争状況、市場シェア ・線維筋痛症治療薬の種類別市場規模（セロトニン・ノルアドレナリン再取り込み阻害薬、GABAアナログ、その他） ・線維筋痛症治療薬の用途別市場規模（病院、クリニック、その他） ・線維筋痛症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・線維筋痛症治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・線維筋痛症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・線維筋痛症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・線維筋痛症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Eli Lilly、Actavis、Merck Sharp and Dohme、Daiichi Sankyo、Innovative Med Concepts、Meda、Meiji Seika、Switch Biotech、Theravance、Zynerba Pharmaceuticals、Tonix Pharmaceuticals Holding Corp. (TNXP)） ・結論

Fibromyalgia (FM) is a medical condition characterised by chronic widespread pain and a heightened pain response to pressure.
The APAC is a major untapped market with many leading vendors in the global fibromyalgia drugs market.

Market Analysis and Insights: Global Fibromyalgia Drugs Market
The global Fibromyalgia Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fibromyalgia Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fibromyalgia Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fibromyalgia Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fibromyalgia Drugs market.

Global Fibromyalgia Drugs Scope and Market Size
Fibromyalgia Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fibromyalgia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Serotonin Norepinephrine Reuptake Inhibitors
GABA Analogs
Other

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Eli Lilly
Actavis
Merck Sharp and Dohme
Daiichi Sankyo
Innovative Med Concepts
Meda
Meiji Seika
Switch Biotech
Merck Sharp and Dohme

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fibromyalgia Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Serotonin Norepinephrine Reuptake Inhibitors
1.2.3 GABA Analogs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Fibromyalgia Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Fibromyalgia Drugs Market Perspective (2016-2027)
2.2 Fibromyalgia Drugs Growth Trends by Regions
2.2.1 Fibromyalgia Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Fibromyalgia Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Fibromyalgia Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Fibromyalgia Drugs Industry Dynamic
2.3.1 Fibromyalgia Drugs Market Trends
2.3.2 Fibromyalgia Drugs Market Drivers
2.3.3 Fibromyalgia Drugs Market Challenges
2.3.4 Fibromyalgia Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Fibromyalgia Drugs Players by Revenue
3.1.1 Global Top Fibromyalgia Drugs Players by Revenue (2016-2021)
3.1.2 Global Fibromyalgia Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Fibromyalgia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fibromyalgia Drugs Revenue
3.4 Global Fibromyalgia Drugs Market Concentration Ratio
3.4.1 Global Fibromyalgia Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Drugs Revenue in 2020
3.5 Fibromyalgia Drugs Key Players Head office and Area Served
3.6 Key Players Fibromyalgia Drugs Product Solution and Service
3.7 Date of Enter into Fibromyalgia Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Fibromyalgia Drugs Breakdown Data by Type
4.1 Global Fibromyalgia Drugs Historic Market Size by Type (2016-2021)
4.2 Global Fibromyalgia Drugs Forecasted Market Size by Type (2022-2027)

5 Fibromyalgia Drugs Breakdown Data by Application
5.1 Global Fibromyalgia Drugs Historic Market Size by Application (2016-2021)
5.2 Global Fibromyalgia Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Fibromyalgia Drugs Market Size (2016-2027)
6.2 North America Fibromyalgia Drugs Market Size by Type
6.2.1 North America Fibromyalgia Drugs Market Size by Type (2016-2021)
6.2.2 North America Fibromyalgia Drugs Market Size by Type (2022-2027)
6.2.3 North America Fibromyalgia Drugs Market Size by Type (2016-2027)
6.3 North America Fibromyalgia Drugs Market Size by Application
6.3.1 North America Fibromyalgia Drugs Market Size by Application (2016-2021)
6.3.2 North America Fibromyalgia Drugs Market Size by Application (2022-2027)
6.3.3 North America Fibromyalgia Drugs Market Size by Application (2016-2027)
6.4 North America Fibromyalgia Drugs Market Size by Country
6.4.1 North America Fibromyalgia Drugs Market Size by Country (2016-2021)
6.4.2 North America Fibromyalgia Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Fibromyalgia Drugs Market Size (2016-2027)
7.2 Europe Fibromyalgia Drugs Market Size by Type
7.2.1 Europe Fibromyalgia Drugs Market Size by Type (2016-2021)
7.2.2 Europe Fibromyalgia Drugs Market Size by Type (2022-2027)
7.2.3 Europe Fibromyalgia Drugs Market Size by Type (2016-2027)
7.3 Europe Fibromyalgia Drugs Market Size by Application
7.3.1 Europe Fibromyalgia Drugs Market Size by Application (2016-2021)
7.3.2 Europe Fibromyalgia Drugs Market Size by Application (2022-2027)
7.3.3 Europe Fibromyalgia Drugs Market Size by Application (2016-2027)
7.4 Europe Fibromyalgia Drugs Market Size by Country
7.4.1 Europe Fibromyalgia Drugs Market Size by Country (2016-2021)
7.4.2 Europe Fibromyalgia Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Fibromyalgia Drugs Market Size (2016-2027)
8.2 Asia-Pacific Fibromyalgia Drugs Market Size by Type
8.2.1 Asia-Pacific Fibromyalgia Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Fibromyalgia Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Fibromyalgia Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Fibromyalgia Drugs Market Size by Application
8.3.1 Asia-Pacific Fibromyalgia Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Fibromyalgia Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Fibromyalgia Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Fibromyalgia Drugs Market Size by Region
8.4.1 Asia-Pacific Fibromyalgia Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Fibromyalgia Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Fibromyalgia Drugs Market Size (2016-2027)
9.2 Latin America Fibromyalgia Drugs Market Size by Type
9.2.1 Latin America Fibromyalgia Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Fibromyalgia Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Fibromyalgia Drugs Market Size by Type (2016-2027)
9.3 Latin America Fibromyalgia Drugs Market Size by Application
9.3.1 Latin America Fibromyalgia Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Fibromyalgia Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Fibromyalgia Drugs Market Size by Application (2016-2027)
9.4 Latin America Fibromyalgia Drugs Market Size by Country
9.4.1 Latin America Fibromyalgia Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Fibromyalgia Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Fibromyalgia Drugs Market Size (2016-2027)
10.2 Middle East & Africa Fibromyalgia Drugs Market Size by Type
10.2.1 Middle East & Africa Fibromyalgia Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Fibromyalgia Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Fibromyalgia Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Fibromyalgia Drugs Market Size by Application
10.3.1 Middle East & Africa Fibromyalgia Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Fibromyalgia Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Fibromyalgia Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Fibromyalgia Drugs Market Size by Country
10.4.1 Middle East & Africa Fibromyalgia Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Fibromyalgia Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Fibromyalgia Drugs Introduction
11.1.4 Pfizer Revenue in Fibromyalgia Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Fibromyalgia Drugs Introduction
11.2.4 Eli Lilly Revenue in Fibromyalgia Drugs Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 Actavis
11.3.1 Actavis Company Details
11.3.2 Actavis Business Overview
11.3.3 Actavis Fibromyalgia Drugs Introduction
11.3.4 Actavis Revenue in Fibromyalgia Drugs Business (2016-2021)
11.3.5 Actavis Recent Development
11.4 Merck Sharp and Dohme
11.4.1 Merck Sharp and Dohme Company Details
11.4.2 Merck Sharp and Dohme Business Overview
11.4.3 Merck Sharp and Dohme Fibromyalgia Drugs Introduction
11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Drugs Business (2016-2021)
11.4.5 Merck Sharp and Dohme Recent Development
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Details
11.5.2 Daiichi Sankyo Business Overview
11.5.3 Daiichi Sankyo Fibromyalgia Drugs Introduction
11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Drugs Business (2016-2021)
11.5.5 Daiichi Sankyo Recent Development
11.6 Innovative Med Concepts
11.6.1 Innovative Med Concepts Company Details
11.6.2 Innovative Med Concepts Business Overview
11.6.3 Innovative Med Concepts Fibromyalgia Drugs Introduction
11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Drugs Business (2016-2021)
11.6.5 Innovative Med Concepts Recent Development
11.7 Meda
11.7.1 Meda Company Details
11.7.2 Meda Business Overview
11.7.3 Meda Fibromyalgia Drugs Introduction
11.7.4 Meda Revenue in Fibromyalgia Drugs Business (2016-2021)
11.7.5 Meda Recent Development
11.8 Meiji Seika
11.8.1 Meiji Seika Company Details
11.8.2 Meiji Seika Business Overview
11.8.3 Meiji Seika Fibromyalgia Drugs Introduction
11.8.4 Meiji Seika Revenue in Fibromyalgia Drugs Business (2016-2021)
11.8.5 Meiji Seika Recent Development
11.9 Switch Biotech
11.9.1 Switch Biotech Company Details
11.9.2 Switch Biotech Business Overview
11.9.3 Switch Biotech Fibromyalgia Drugs Introduction
11.9.4 Switch Biotech Revenue in Fibromyalgia Drugs Business (2016-2021)
11.9.5 Switch Biotech Recent Development
11.10 Theravance
11.10.1 Theravance Company Details
11.10.2 Theravance Business Overview
11.10.3 Theravance Fibromyalgia Drugs Introduction
11.10.4 Theravance Revenue in Fibromyalgia Drugs Business (2016-2021)
11.10.5 Theravance Recent Development
11.11 Zynerba Pharmaceuticals
11.11.1 Zynerba Pharmaceuticals Company Details
11.11.2 Zynerba Pharmaceuticals Business Overview
11.11.3 Zynerba Pharmaceuticals Fibromyalgia Drugs Introduction
11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Drugs Business (2016-2021)
11.11.5 Zynerba Pharmaceuticals Recent Development
11.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Introduction
11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Drugs Business (2016-2021)
11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Fibromyalgia Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Serotonin Norepinephrine Reuptake Inhibitors
Table 3. Key Players of GABA Analogs
Table 4. Key Players of Other
Table 5. Global Fibromyalgia Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Fibromyalgia Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Fibromyalgia Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Fibromyalgia Drugs Market Share by Regions (2016-2021)
Table 9. Global Fibromyalgia Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Fibromyalgia Drugs Market Share by Regions (2022-2027)
Table 11. Fibromyalgia Drugs Market Trends
Table 12. Fibromyalgia Drugs Market Drivers
Table 13. Fibromyalgia Drugs Market Challenges
Table 14. Fibromyalgia Drugs Market Restraints
Table 15. Global Fibromyalgia Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Fibromyalgia Drugs Market Share by Players (2016-2021)
Table 17. Global Top Fibromyalgia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Drugs as of 2020)
Table 18. Ranking of Global Top Fibromyalgia Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Fibromyalgia Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Fibromyalgia Drugs Product Solution and Service
Table 22. Date of Enter into Fibromyalgia Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Fibromyalgia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Fibromyalgia Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Fibromyalgia Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Fibromyalgia Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Fibromyalgia Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Fibromyalgia Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Fibromyalgia Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Fibromyalgia Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Fibromyalgia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Fibromyalgia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Fibromyalgia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Fibromyalgia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Fibromyalgia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Fibromyalgia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Fibromyalgia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Fibromyalgia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Fibromyalgia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Fibromyalgia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Fibromyalgia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Fibromyalgia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Fibromyalgia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Fibromyalgia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Fibromyalgia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Fibromyalgia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Fibromyalgia Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Fibromyalgia Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Fibromyalgia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Fibromyalgia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Fibromyalgia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Fibromyalgia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Fibromyalgia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Fibromyalgia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Fibromyalgia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Fibromyalgia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Fibromyalgia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Fibromyalgia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Fibromyalgia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Fibromyalgia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Fibromyalgia Drugs Product
Table 65. Pfizer Revenue in Fibromyalgia Drugs Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Eli Lilly Company Details
Table 68. Eli Lilly Business Overview
Table 69. Eli Lilly Fibromyalgia Drugs Product
Table 70. Eli Lilly Revenue in Fibromyalgia Drugs Business (2016-2021) & (US$ Million)
Table 71. Eli Lilly Recent Development
Table 72. Actavis Company Details
Table 73. Actavis Business Overview
Table 74. Actavis Fibromyalgia Drugs Product
Table 75. Actavis Revenue in Fibromyalgia Drugs Business (2016-2021) & (US$ Million)
Table 76. Actavis Recent Development
Table 77. Merck Sharp and Dohme Company Details
Table 78. Merck Sharp and Dohme Business Overview
Table 79. Merck Sharp and Dohme Fibromyalgia Drugs Product
Table 80. Merck Sharp and Dohme Revenue in Fibromyalgia Drugs Business (2016-2021) & (US$ Million)
Table 81. Merck Sharp and Dohme Recent Development
Table 82. Daiichi Sankyo Company Details
Table 83. Daiichi Sankyo Business Overview
Table 84. Daiichi Sankyo Fibromyalgia Drugs Product
Table 85. Daiichi Sankyo Revenue in Fibromyalgia Drugs Business (2016-2021) & (US$ Million)
Table 86. Daiichi Sankyo Recent Development
Table 87. Innovative Med Concepts Company Details
Table 88. Innovative Med Concepts Business Overview
Table 89. Innovative Med Concepts Fibromyalgia Drugs Product
Table 90. Innovative Med Concepts Revenue in Fibromyalgia Drugs Business (2016-2021) & (US$ Million)
Table 91. Innovative Med Concepts Recent Development
Table 92. Meda Company Details
Table 93. Meda Business Overview
Table 94. Meda Fibromyalgia Drugs Product
Table 95. Meda Revenue in Fibromyalgia Drugs Business (2016-2021) & (US$ Million)
Table 96. Meda Recent Development
Table 97. Meiji Seika Company Details
Table 98. Meiji Seika Business Overview
Table 99. Meiji Seika Revenue in Fibromyalgia Drugs Business (2016-2021) & (US$ Million)
Table 100. Meiji Seika Recent Development
Table 101. Switch Biotech Company Details
Table 102. Switch Biotech Business Overview
Table 103. Switch Biotech Fibromyalgia Drugs Product
Table 104. Switch Biotech Revenue in Fibromyalgia Drugs Business (2016-2021) & (US$ Million)
Table 105. Switch Biotech Recent Development
Table 106. Theravance Company Details
Table 107. Theravance Business Overview
Table 108. Theravance Fibromyalgia Drugs Product
Table 109. Theravance Revenue in Fibromyalgia Drugs Business (2016-2021) & (US$ Million)
Table 110. Theravance Recent Development
Table 111. Zynerba Pharmaceuticals Company Details
Table 112. Zynerba Pharmaceuticals Business Overview
Table 113. Zynerba Pharmaceuticals Fibromyalgia Drugs Product
Table 114. Zynerba Pharmaceuticals Revenue in Fibromyalgia Drugs Business (2016-2021) & (US$ Million)
Table 115. Zynerba Pharmaceuticals Recent Development
Table 116. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
Table 117. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
Table 118. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Product
Table 119. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Drugs Business (2016-2021) & (US$ Million)
Table 120. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fibromyalgia Drugs Market Share by Type: 2020 VS 2027
Figure 2. Serotonin Norepinephrine Reuptake Inhibitors Features
Figure 3. GABA Analogs Features
Figure 4. Other Features
Figure 5. Global Fibromyalgia Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Fibromyalgia Drugs Report Years Considered
Figure 10. Global Fibromyalgia Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Fibromyalgia Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Fibromyalgia Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Fibromyalgia Drugs Market Share by Regions (2022-2027)
Figure 14. Global Fibromyalgia Drugs Market Share by Players in 2020
Figure 15. Global Top Fibromyalgia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Fibromyalgia Drugs Revenue in 2020
Figure 17. Global Fibromyalgia Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Fibromyalgia Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Fibromyalgia Drugs Market Share by Type (2016-2027)
Figure 21. North America Fibromyalgia Drugs Market Share by Application (2016-2027)
Figure 22. North America Fibromyalgia Drugs Market Share by Country (2016-2027)
Figure 23. United States Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Fibromyalgia Drugs Market Share by Type (2016-2027)
Figure 27. Europe Fibromyalgia Drugs Market Share by Application (2016-2027)
Figure 28. Europe Fibromyalgia Drugs Market Share by Country (2016-2027)
Figure 29. Germany Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Fibromyalgia Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Fibromyalgia Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Fibromyalgia Drugs Market Share by Region (2016-2027)
Figure 39. China Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Fibromyalgia Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Fibromyalgia Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Fibromyalgia Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Fibromyalgia Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Fibromyalgia Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Fibromyalgia Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Fibromyalgia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Fibromyalgia Drugs Business (2016-2021)
Figure 59. Eli Lilly Revenue Growth Rate in Fibromyalgia Drugs Business (2016-2021)
Figure 60. Actavis Revenue Growth Rate in Fibromyalgia Drugs Business (2016-2021)
Figure 61. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Drugs Business (2016-2021)
Figure 62. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Drugs Business (2016-2021)
Figure 63. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Drugs Business (2016-2021)
Figure 64. Meda Revenue Growth Rate in Fibromyalgia Drugs Business (2016-2021)
Figure 65. Meiji Seika Revenue Growth Rate in Fibromyalgia Drugs Business (2016-2021)
Figure 66. Switch Biotech Revenue Growth Rate in Fibromyalgia Drugs Business (2016-2021)
Figure 67. Theravance Revenue Growth Rate in Fibromyalgia Drugs Business (2016-2021)
Figure 68. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Drugs Business (2016-2021)
Figure 69. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Drugs Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---